News


12 May, 2022
Pneumagen Announces Positive Top Line Results from Phase 1 Study Evaluating Neumifil, a Product Designed for the Prevention and Treatment of Viral Respiratory Tract Infections
09 May, 2022
Pneumagen Announces Appointment of John Beadle as Non-Executive Director
13 Apr, 2022
Pneumagen to present on further significant development for its lead product, Neumifil at BioTrinity 2022
19 Jan, 2022
Pneumagen Raises £3.8 million to Advance the Phase II Clinical Development of Neumifil, a Pan-antiviral, Intranasal Drug for the Prophylaxis and Treatment of Viral Respiratory Tract Infections (RTIs)
10 Nov, 2021
Pneumagen initiates Phase 1 trial of Neumifil, a novel, intranasal pan anti-viral therapeutic for the prophylaxis and treatment of viral Respiratory Tract Infections
01 Nov, 2021
Pneumagen Appoints New Head of Research to Expand its Anti-Viral Pipeline leveraging its Proprietary GlycoTarge™ Platform
08 Mar, 2021
Pneumagen Announces Neumifil™ is Efficacious In an Established Model of COVID-19 Infection
21 Jan, 2021
Pneumagen Announces £2.5m fundraising to advance universal treatment for viral respiratory infections into the clinic this year
05 Oct, 2020
Pneumagen’s Neumifil for combating COVID-19 featured in SCRIP’s 10 to watch at BIO-Europe Digital
16 Sep, 2020
Pneumagen Announces Scientific Advisory Board and Development Team Appointments
27 May, 2020
Pneumagen Announces £4m fundraising and Commits to Clinical Trial Development for COVID-19
08 May, 2020
Pneumagen Ltd’s Recent COVID-19 Data Covered by BBC’s "The Nine"
28 Apr, 2020
Pneumagen Ltd Announces Positive Anti–Viral Activity for Novel Glycan Approach in Preventing COVID–19 Infections
17 Mar, 2020
Pneumagen Ltd Leverages its Novel Glycan Approach to Target Coronavirus (COVID-19) Infections
12 Nov, 2019
Pneumagen Presents Poster on Multivalent Sialic Acid-binding Proteins as a Novel Preventative and Treatment of RSV at RSVVW 2019
15 Oct, 2019
Pneumagen Demonstrates Preclinical Proof-of-Concept in Oncology for Neumonco, a Novel Carbohydrate Binding Module
10 Sep, 2019
Pneumagen Demonstrates Preclinical Proof-of-Concept for Neumifil™ in Respiratory Syncytial Virus Infections
28 Aug, 2019
Pneumagen Appoints Scientific Advisory Board
01 Mar, 2015
Publication - Sialic Acid-Binding Protein Sp2CBMTD Protects Mice against Lethal Challenge with Emerging Influenza A (H7N9) Virus
06 Mar, 2014
PUBLICATION - Prevention of influenza by targeting host receptors using engineered proteins